Abstract
Background
The Akt signaling pathway controls the survival and growth of human cancers. We investigated the expression of phosphorylated Akt (pAkt) in patients with gastric cancer.
Methods
The expression of pAkt was immunohistochemically examined in 140 gastric cancer patients who underwent a gastrectomy. The expression of pAkt was evaluated based on staining intensity, and staining was classified as negative or positive. We examined the expression of pAkt and its association with the clinicopathological findings, prognosis, depth of invasion, the expression of p53, and efficacy of oral fluorouracil chemotherapy after surgery.
Results
Expression of pAkt was positive in 81 (58%) patients and negative in 59 (42%) patients. There were no significant correlations between pAkt expression and the clinicopathological findings. The prognosis of patients with pAkt-negative tumors was superior to that of patients with pAkt-positive tumors, and the difference was significant for T3/T4 gastric cancer (P < 0.05). Among the patients with T3/T4 gastric cancer, postoperative oral fluorouracil treatment was effective in those who were pAkt-positive. Multivariate analysis revealed that pAkt expression and lymph node metastasis were independent prognostic factors. In 88 patients with T3 gastric carcinoma who had undergone curative surgery, in whom we studied the prognostic impact of a combined analysis of pAkt and p53 expression, patients with both pAkt- and p53-positive tumors showed a significantly poorer prognosis than patients with either or both pAkt- and p53-negative tumors (P < 0.05).
Conclusion
Our results indicate that pAkt expression may be useful for predicting the prognosis and efficacy of fluorouracil treatment in patients with gastric cancer.
Article PDF
Similar content being viewed by others
References
MD Jacobson M Weil MC Raff (1997) ArticleTitleProgrammed cell death in animal development Cell 88 347–54 Occurrence Handle9039261 Occurrence Handle10.1016/S0092-8674(00)81873-5 Occurrence Handle1:CAS:528:DyaK2sXhtFahtbw%3D
DA Fruman RE Meyers LC Cantley (1998) ArticleTitlePhosphoinositide kinases Annu Rev Biochem 67 481–507 Occurrence Handle9759495 Occurrence Handle10.1146/annurev.biochem.67.1.481 Occurrence Handle1:CAS:528:DyaK1cXlsFOmsb4%3D
TF Franke DR Kaplan LC Cantley (1997) ArticleTitlePI3K: downstream AKTion blocks apoptosis Cell 88 435–7 Occurrence Handle9038334 Occurrence Handle10.1016/S0092-8674(00)81883-8 Occurrence Handle1:CAS:528:DyaK2sXhtlKqs70%3D
LC Cantley BG Neel (1999) ArticleTitleNew insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway Proc Natl Acad Sci USA 96 4240–5 Occurrence Handle10200246 Occurrence Handle10.1073/pnas.96.8.4240 Occurrence Handle1:CAS:528:DyaK1MXjs1ymtbg%3D
HW Chang M Aoki D Fruman KR Auger A Bellacosa PN Tsichlis et al. (1997) ArticleTitleTransformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase Science 276 1848–50 Occurrence Handle9188528 Occurrence Handle10.1126/science.276.5320.1848 Occurrence Handle1:CAS:528:DyaK2sXksVCgu7k%3D
CA Conover LK Bale SK Durham DR Powell (2000) ArticleTitleInsulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity Endocrinology 141 3098–103 Occurrence Handle10965879 Occurrence Handle10.1210/en.141.9.3098 Occurrence Handle1:CAS:528:DC%2BD3cXmtVers7o%3D
SR Datta A Brunet ME Greenberg (1999) ArticleTitleCellular survival: a play in three Akts Genes Dev 13 2905–27 Occurrence Handle10579998 Occurrence Handle10.1101/gad.13.22.2905 Occurrence Handle1:CAS:528:DyaK1MXnvVCltLo%3D
S Masure B Haefner JJ Wesselink E Hoefnagel E Mortier P Verhasselt et al. (1999) ArticleTitleMolecular cloning, expression and characterization of the human serine/threonine kinase Akt-3 Eur J Biochem 265 353–60 Occurrence Handle10491192 Occurrence Handle10.1046/j.1432-1327.1999.00774.x Occurrence Handle1:CAS:528:DyaK1MXmsFKksLY%3D
K Nakatani H Sakaue DA Thompson RJ Weigel RA Roth (1999) ArticleTitleIdentification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site Biochem Biophys Res Commun 257 906–10 Occurrence Handle10208883 Occurrence Handle10.1006/bbrc.1999.0559 Occurrence Handle1:CAS:528:DyaK1MXisVahsrY%3D
ZQ Yuan M Sun RI Feldman G Wang X Ma C Jiang et al. (2000) ArticleTitleFrequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer Oncogene 19 2324–30 Occurrence Handle10822383 Occurrence Handle10.1038/sj.onc.1203598 Occurrence Handle1:CAS:528:DC%2BD3cXjslelsLk%3D
C Page HJ Lin Y Jin VP Castle G Nunez M Huang et al. (2000) ArticleTitleOverexpression of Akt/AKT can modulate chemotherapy-induced apoptosis Anticancer Res 20 407–16 Occurrence Handle10769688 Occurrence Handle1:CAS:528:DC%2BD3cXisl2ntL4%3D
N Itoh S Semba M Ito H Takeda S Kawata M Yamakawa (2002) ArticleTitlePhosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma Cancer 94 3127–34 Occurrence Handle12115344 Occurrence Handle10.1002/cncr.10591 Occurrence Handle1:CAS:528:DC%2BD38XltlOqtbk%3D
G Perez-Tenorio O Stal (2002) ArticleTitleActivation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients Br J Cancer 86 540–5 Occurrence Handle11870534 Occurrence Handle10.1038/sj.bjc.6600126 Occurrence Handle1:CAS:528:DC%2BD38XislCmtro%3D
InstitutionalAuthorNameJapanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma Kanehara Tokyo
Y Gomyo M Ikeda M Osaki S Tatebe S Tsujitani M Ikeguchi et al. (1997) ArticleTitleExpression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in survival of patients with advanced gastric carcinoma Cancer 79 2067–72 Occurrence Handle9179052 Occurrence Handle10.1002/(SICI)1097-0142(19970601)79:11<2067::AID-CNCR3>3.0.CO;2-M Occurrence Handle1:CAS:528:DyaK2sXjs1yksL4%3D
J Downward (1998) ArticleTitleRas signalling and apoptosis Curr Opin Genet Dev 8 49–54 Occurrence Handle9529605 Occurrence Handle10.1016/S0959-437X(98)80061-0 Occurrence Handle1:CAS:528:DyaK1cXit1Gmtro%3D
SJ Grille A Bellacosa J Upson AJ Klein-Szanto F van Roy W Lee-Kwon et al. (2003) ArticleTitleThe protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines Cancer Res 63 2172–8 Occurrence Handle12727836 Occurrence Handle1:CAS:528:DC%2BD3sXjtlGmtrk%3D
JI Kreisberg SN Malik TJ Prihoda RG Bedolla DA Troyer S Kreisberg et al. (2004) ArticleTitlePhosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer Cancer Res 64 5232–6 Occurrence Handle15289328 Occurrence Handle10.1158/0008-5472.CAN-04-0272 Occurrence Handle1:CAS:528:DC%2BD2cXmtF2mtbo%3D
J Brognard AS Clark Y Ni PA Dennis (2001) ArticleTitleAkt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Res 61 3986–97 Occurrence Handle11358816 Occurrence Handle1:CAS:528:DC%2BD3MXktVWqsbw%3D
J Brognard PA Dennis (2002) ArticleTitleVariable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants Cell Death Differ 9 893–904 Occurrence Handle12181740 Occurrence Handle10.1038/sj.cdd.4401054 Occurrence Handle1:CAS:528:DC%2BD38XmtVOnu7g%3D
AS Clark K West S Streicher PA Dennis (2002) ArticleTitleConstitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells Mol Cancer Ther 1 707–17 Occurrence Handle12479367 Occurrence Handle1:CAS:528:DC%2BD38XlsFSmtLk%3D
AS Clark KA West PM Blumberg PA Dennis (2003) ArticleTitleAltered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance Cancer Res 63 780–6 Occurrence Handle12591726 Occurrence Handle1:CAS:528:DC%2BD3sXht1Gqs7w%3D
KA West SS Castillo PA Dennis (2002) ArticleTitleActivation of the PI3K/Akt pathway and chemotherapeutic resistance Drug Resist Update 5 234–48 Occurrence Handle10.1016/S1368-7646(02)00120-6 Occurrence Handle1:CAS:528:DC%2BD3sXhtlShtbg%3D
A Balendran A Casamayor M Deak A Paterson P Gaffney R Currie et al. (1999) ArticleTitlePDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2 Curr Biol 9 393–404 Occurrence Handle10226025 Occurrence Handle10.1016/S0960-9822(99)80186-9 Occurrence Handle1:CAS:528:DyaK1MXislCqsLc%3D
MH Cardone N Roy HR Stennicke GS Salvesen TF Franke E Stanbridge et al. (1998) ArticleTitleRegulation of cell death protease caspase-9 by phosphorylation Science 282 1318–21 Occurrence Handle9812896 Occurrence Handle10.1126/science.282.5392.1318 Occurrence Handle1:CAS:528:DyaK1cXnsFentLY%3D
A Brunet A Bonni MJ Zigmond MZ Lin P Juo LS Hu et al. (1999) ArticleTitleAkt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor Cell 96 857–68 Occurrence Handle10102273 Occurrence Handle10.1016/S0092-8674(00)80595-4 Occurrence Handle1:CAS:528:DyaK1MXitFGgsr0%3D
S Yoshioka (2005) ArticleTitleThe PI3K-Akt pathway in SN-38-induced apoptosis in human gastric cancer cell lines Yonago Acta Medica 48 7–16 Occurrence Handle1:CAS:528:DC%2BD2MXivVCntb8%3D
E Oki H Baba E Tokunaga T Nakamura N Ueda M Futatsugi et al. (2005) ArticleTitleAkt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer Int J Cancer 117 376–80 Occurrence Handle15900596 Occurrence Handle10.1002/ijc.21170 Occurrence Handle1:CAS:528:DC%2BD2MXhtFant7rJ
HQ Wang T Quan T He TF Franke JJ Voorhees GJ Fisher (2003) ArticleTitleEpidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspase-3, -8, and -9 in human keratinocytes J Biol Chem 278 45737–45 Occurrence Handle12952968 Occurrence Handle10.1074/jbc.M300574200 Occurrence Handle1:CAS:528:DC%2BD3sXosl2isbc%3D
X Ling RJ Bernacki MG Brattain F Li (2004) ArticleTitleInduction of survivin expression by Taxol (paclitaxel) is an early event, which is independent of Taxol-mediated G2/M arrest J Biol Chem 279 15196–203 Occurrence Handle14722122 Occurrence Handle10.1074/jbc.M310947200 Occurrence Handle1:CAS:528:DC%2BD2cXivVKgs7g%3D
J Hayakawa M Ohmichi H Kurachi Y Kanda K Hisamoto Y Nishio et al. (2000) ArticleTitleInhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin Cancer Res 60 5988–94 Occurrence Handle11085518 Occurrence Handle1:CAS:528:DC%2BD3cXotV2ls7o%3D
M Gorospe X Wang NJ Holbrook (1999) ArticleTitleFunctional role of p21 during the cellular response to stress Gene Expr 7 377–85 Occurrence Handle10440238 Occurrence Handle1:CAS:528:DyaK1MXltVKmtLc%3D
LD Mayo DB Donner (2001) ArticleTitleA phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus Proc Natl Acad Sci USA 98 11598–603 Occurrence Handle11504915 Occurrence Handle10.1073/pnas.181181198 Occurrence Handle1:CAS:528:DC%2BD3MXnt12js7s%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murakami, D., Tsujitani, S., Osaki, T. et al. Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy. Gastric Cancer 10, 45–51 (2007). https://doi.org/10.1007/s10120-006-0410-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10120-006-0410-7